The Efficacy and Safety of Continued Hydroxyurea Therapy Versus Switching to Ruxolitinib in Patients with Polycythemia Vera: A Randomized, Double-Blind, Double-Dummy, Symptom Study (RELIEF)

Authors
Category Primary study
JournalBlood
Year 2014
This article has no abstract
Epistemonikos ID: 481a8b714a33fb3d7be4a6eee82c62abea1e9ae5
First added on: Feb 19, 2025